Rizatriptan-Mepha oro 5 mg
Rizatriptan-Mepha oro 5 mg is a medicine authorised by Swissmedic under authorisation number 65799. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 May 2015 and the authorisation is valid without a time limit. ATC code N02CC04 places the medicine in the group Analgesics.
| Authorisation number | 65799 |
|---|---|
| Name | Rizatriptan-Mepha oro 5 mg |
| Full name | Rizatriptan-Mepha oro 5 mg, Schmelztabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02CC04 |
| First authorisation | 22 May 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rizatriptan-Mepha oro 5 mg, Schmelztabletten | B | 22 May 2015 |
| 2 | Rizatriptan-Mepha oro 10 mg, Schmelztabletten | B | 22 May 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 6 | Tablette(n) | N02CC04 | 02.05.1. | B |
| 2 | 3 | Tablette(n) | N02CC04 | 02.05.1. | B |
| 3 | 6 | Tablette(n) | N02CC04 | 02.05.1. | B |
| 4 | 12 | Tablette(n) | N02CC04 | 02.05.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rizatriptan-Mepha oro 5 mg authorised in Switzerland?
Yes. Rizatriptan-Mepha oro 5 mg is authorised by Swissmedic under authorisation number 65799, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rizatriptan-Mepha oro 5 mg have?
Rizatriptan-Mepha oro 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rizatriptan-Mepha oro 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.